Neil S. Horowitz

1.2k total citations
29 papers, 854 citations indexed

About

Neil S. Horowitz is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Epidemiology. According to data from OpenAlex, Neil S. Horowitz has authored 29 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Obstetrics and Gynecology, 17 papers in Reproductive Medicine and 8 papers in Epidemiology. Recurrent topics in Neil S. Horowitz's work include Endometrial and Cervical Cancer Treatments (23 papers), Ovarian cancer diagnosis and treatment (16 papers) and Cervical Cancer and HPV Research (7 papers). Neil S. Horowitz is often cited by papers focused on Endometrial and Cervical Cancer Treatments (23 papers), Ovarian cancer diagnosis and treatment (16 papers) and Cervical Cancer and HPV Research (7 papers). Neil S. Horowitz collaborates with scholars based in United States, Canada and United Kingdom. Neil S. Horowitz's co-authors include David G. Mutch, Marcela G. del Carmen, John O. Schorge, David M. Boruta, J. Alejandro Rauh‐Hain, Annekathryn Goodman, Whitfield B. Growdon, Taymaa May, David E. Cohn and Seok‐Mo Kim and has published in prestigious journals such as Cancer, Obstetrics and Gynecology and Gynecologic Oncology.

In The Last Decade

Neil S. Horowitz

25 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil S. Horowitz United States 17 680 512 187 161 103 29 854
Marika C. Stenfert Kroese Netherlands 10 684 1.0× 529 1.0× 148 0.8× 138 0.9× 176 1.7× 14 902
JJ Jobsen Netherlands 4 775 1.1× 568 1.1× 190 1.0× 163 1.0× 70 0.7× 7 832
J. A. Lejárcegui Spain 13 422 0.6× 351 0.7× 159 0.9× 185 1.1× 87 0.8× 21 674
Shinichiro Minobe Japan 16 562 0.8× 385 0.8× 194 1.0× 231 1.4× 222 2.2× 50 821
Kanishka Karunaratne Sri Lanka 4 511 0.8× 216 0.4× 342 1.8× 142 0.9× 197 1.9× 7 697
Amandine Maulard France 15 590 0.9× 545 1.1× 240 1.3× 180 1.1× 245 2.4× 54 904
Adriana Bermúdez Argentina 8 789 1.2× 356 0.7× 519 2.8× 287 1.8× 258 2.5× 16 1.0k
Alexandre Bricou France 16 733 1.1× 697 1.4× 107 0.6× 284 1.8× 86 0.8× 79 1.1k
Berta Díaz‐Feijoó Spain 19 766 1.1× 446 0.9× 231 1.2× 288 1.8× 150 1.5× 92 1.0k
Luis Chiva Spain 14 348 0.5× 430 0.8× 74 0.4× 246 1.5× 109 1.1× 76 644

Countries citing papers authored by Neil S. Horowitz

Since Specialization
Citations

This map shows the geographic impact of Neil S. Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil S. Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil S. Horowitz more than expected).

Fields of papers citing papers by Neil S. Horowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil S. Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil S. Horowitz. The network helps show where Neil S. Horowitz may publish in the future.

Co-authorship network of co-authors of Neil S. Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Neil S. Horowitz. A scholar is included among the top collaborators of Neil S. Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil S. Horowitz. Neil S. Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feltmate, Colleen M., Jessica D. St. Laurent, Taymaa May, et al.. (2025). Trends in sentinel lymph node evaluation for vulvar melanoma in the United States from 2012 to 2018. Gynecologic Oncology. 196. 175–181.
2.
Fitzgerald, Kelly, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis, et al.. (2025). A phase I clinical trial of radiation therapy, durvalumab and tremelimumab in recurrent gynecologic cancer. Gynecologic Oncology. 197. 51–56.
3.
Elias, Kevin M., et al.. (2024). Initial Diagnosis and Treatment of Low-Risk Gestational Trophoblastic Neoplasia. Hematology/Oncology Clinics of North America. 38(6). 1233–1244.
4.
Aviki, Emeline, Katharine M. Esselen, Marisa R. Nucci, et al.. (2015). Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva?. Gynecologic Oncology. 137(1). 60–65. 17 indexed citations
5.
Zaino, Richard J., William E. Brady, Kimberly K. Leslie, et al.. (2014). Histologic Effects of Medroxyprogesterone Acetate on Endometrioid Endometrial Adenocarcinoma. International Journal of Gynecological Pathology. 33(6). 543–553. 31 indexed citations
6.
Worley, Michael J., Michelle Davis, Michael G. Muto, et al.. (2014). Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma. Gynecologic Oncology. 135(1). 54–57. 2 indexed citations
7.
Davis, Michelle, J. Alejandro Rauh‐Hain, David M. Boruta, et al.. (2014). Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Gynecologic Oncology. 132(3). 760–766. 47 indexed citations
8.
Vargas, Roberto, J. Alejandro Rauh‐Hain, Joel Clemmer, et al.. (2014). Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: A SEER analysis. Gynecologic Oncology. 133(2). 216–220. 114 indexed citations
9.
Growdon, Whitfield B., Leslie A. Garrett, John O. Schorge, et al.. (2012). Prognostic Determinants in Patients With Stage I Uterine Papillary Serous Carcinoma. International Journal of Gynecological Cancer. 22(3). 417–424. 22 indexed citations
10.
Siegel, Cary, Rochelle F. Andreotti, Higinia R. Cárdenes, et al.. (2012). ACR Appropriateness Criteria® Pretreatment Planning of Invasive Cancer of the Cervix. Journal of the American College of Radiology. 9(6). 395–402. 32 indexed citations
11.
Quick, Charles M., Taymaa May, Neil S. Horowitz, & Marisa R. Nucci. (2012). Low-grade, Low-stage Endometrioid Endometrial Adenocarcinoma. International Journal of Gynecological Pathology. 31(4). 337–343. 46 indexed citations
12.
Dubinsky, Theodore J., Rochelle F. Andreotti, Higinia R. Cárdenes, et al.. (2011). ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer of the Uterus. Ultrasound Quarterly. 27(2). 139–145. 18 indexed citations
13.
Rauh‐Hain, J. Alejandro, Whitfield B. Growdon, John O. Schorge, et al.. (2010). Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma. Gynecologic Oncology. 119(2). 299–304. 32 indexed citations
14.
Olawaiye, Alexander, Lisa M. Lee, Carolyn Krasner, & Neil S. Horowitz. (2007). Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva. Gynecologic Oncology. 106(3). 628–630. 24 indexed citations
15.
Hoffman, Karen E., Neil S. Horowitz, & Anthony H. Russell. (2007). Healing of vulvo-vaginal radionecrosis following revascularization. Gynecologic Oncology. 106(1). 262–264. 5 indexed citations
16.
Horowitz, Neil S., Farrokh Dehdashti, Thomas J. Herzog, et al.. (2004). Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecologic Oncology. 95(3). 546–551. 119 indexed citations
17.
Horowitz, Neil S., Matthew A. Powell, Charles W. Drescher, et al.. (2003). Adequate staging for uterine cancer can be performed through Pfannenstiel incisions☆. Gynecologic Oncology. 88(3). 404–410. 7 indexed citations
18.
Horowitz, Neil S., William A. Peters, Michael Smith, et al.. (2002). Adjuvant High Dose Rate Vaginal Brachytherapy as Treatment of Stage I and II Endometrial Carcinoma. Obstetrics and Gynecology. 99(2). 235–240. 23 indexed citations
19.
Cohn, David E., Neil S. Horowitz, David G. Mutch, et al.. (2002). Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer?. Gynecologic Oncology. 87(3). 243–246. 100 indexed citations
20.
Horowitz, Neil S. & Janet S. Rader. (2001). ROLE OF THE ULTRASONIC SURGICAL ASPIRATOR IN GYNECOLOGY. Obstetrics and Gynecology Clinics of North America. 28(4). 775–790. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marika C. Stenfert Kroese Breakdown of academic impact, for papers by JJ Jobsen Breakdown of academic impact, for papers by J. A. Lejárcegui Breakdown of academic impact, for papers by Shinichiro Minobe Breakdown of academic impact, for papers by Kanishka Karunaratne Breakdown of academic impact, for papers by Amandine Maulard Breakdown of academic impact, for papers by Adriana Bermúdez Breakdown of academic impact, for papers by Alexandre Bricou Breakdown of academic impact, for papers by Berta Díaz‐Feijoó Breakdown of academic impact, for papers by Luis Chiva
Rankless by CCL
2026